Lidocaina Cloridrato Monico (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve cells, preventing the influx of sodium ions that is required for the generation and propagation of action potentials. By inhibiting these electrical signals, lidocaine stops nerve impulse transmission, resulting in reversible loss of sensation in the area where it is applied.

The appropriate dose of Lidocaina Cloridrato Monico is determined by the prescribing clinician based on the procedure, patient weight, and clinical guidelines. Healthcare professionals calculate the dose to stay within safe maximum limits and adjust it according to individual patient factors.

Safety data for lidocaine in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant. Clinicians should evaluate the risk‑benefit profile and consider alternative options when possible.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lidocaine is a widely used amide‑type local anesthetic offering rapid onset and moderate duration of action. Compared with alternatives such as bupivacaine, lidocaine has a shorter duration but a lower risk of cardiotoxicity, making it suitable for shorter procedures where quick recovery of sensation is desired.

Lidocaina Cloridrato Monico should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and sterility.

The product is administered by infiltration, where the sterile solution is injected directly into the tissue requiring anesthesia. Proper aseptic technique, aspiration before injection, and careful dosing are essential to achieve effective local anesthesia while minimizing systemic exposure.

Serious risks include systemic toxicity leading to central nervous system depression, seizures, or cardiac arrhythmias, as well as severe allergic reactions such as anaphylaxis. Prompt recognition of symptoms and immediate medical intervention are critical to manage these rare but potentially life‑threatening events.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid this product. Additionally, individuals with severe cardiac conduction disorders, uncontrolled epilepsy, or those receiving interacting medications listed under major interactions should be evaluated carefully before use.